, Test f#Bank f#For f#Abrams’ f#Clinical f#Drug f#Therapy f#Rationales f#for f#Nursing f#Practice f#12th
f#Edition f#Geralyn f#Frandsen f#- f#ISBN/ISSN f#9781975136130
Table f#of f#Content
SECTION f#1 f#The f#Conceptual f#Framework f#of f#Pharmacology
f# Chapter f#1 f#The f#Foundation f#of f#Pharmacology: f#Quality f#and
Safety f#Chapter f#2 f#Basic f#Concepts f#and f#Processes
f#
Chapter f#3 f#Medication f#Administration f#and f#the f#Nursing f#Process f#of f#Drug f#Therapy
SECTION f#2 f#Drug f#Therapy f#Throughout f#the f#Lifespan
Chapter f#4 f#Pharmacology f#and f#the f#Care f#of f#Infants f#and f#Pediatric f#Patients f#Medication
Administration f#in f#Pediatrics
f#
Chapter f#5 f#Pharmacology f#and f#the f#Care f#of f#Adults f#and f#Geriatric
f# Patients f#Chapter f#6 f#Pharmacology f#and f#the f#Care f#of f#Pregnant f#or
f# Lactating f#Woman f#Chapter f#7 f#Pharmacology f#and f#Women’s f#Health
Chapter f#8 f#Pharmacology f#and f#Men’s f#Health
SECTION f#3 f#Drugs f#Affecting f#the f#Hematopoietic f#and f#Immune f#Systems
Chapter f#9 f#Drug f#Therapy f#for f#Coagulation f#Disorders
f# Chapter f#10 f#Drug f#Therapy f#for f#Dyslipidemia
Chapter f#11 f#Drug f#Therapy f#for f#Hematopoietic
Disorders f#Chapter f#12 f#Drug f#Therapy:
f#
f# Immunizations
Chapter f#13 f#Drug f#Therapy f#to f#Decrease f#Immunity
f# Chapter f#14 f#Drug f#Therapy f#for f#the f#Treatment f#of
Cancer
f#
,SECTION f#4 f#Drugs f#Affecting f#Inflammation f#and f#Infection
Chapter f#15 f#Inflammation, f#Infection, f#and f#the f#Use f#of f#Antimicrobial
Agents f#Chapter f#16 f#Drug f#Therapy f#to f#Decrease f#Pain, f#Fever, f#and
f#
f# Inflammation f#Chapter f#17 f#Drug f#Therapy f#With f#Corticosteroids
Chapter f#18 f#Drug f#Therapy f#With f#Beta-Lactam f#Antibacterial f#Agents
f# Chapter f#19 f#Drug f#Therapy f#With f#Aminoglycosides f#and
Fluoroquinolones
f#
Chapter f#20 f#Drug f#Therapy f#With f#Tetracyclines, f#Sulfonamides, f#and f#Urinary
f# Antiseptics f#Chapter f#21 f#Drug f#Therapy f#With f#Macrolides f#and f#Miscellaneous f#Anti-
infective f#Agents f#Chapter f#22 f#Drug f#Therapy f#for f#Tuberculosis f#and f#Mycobacterium
avium f#Complex f#Disease f#Chapter f#23 f#Drug f#Therapy f#for f#Viral f#Infections
f#
Chapter f#24 f#Drug f#Therapy f#for f#Fungal f#Infections
f# Chapter f#25 f#Drug f#Therapy f#for f#Parasitic f#Infections
SECTION f#5 f#Drugs f#Affecting f#the f#Cardiovascular f#System
Chapter 26
f# Drug
f# Therapy
f# f# for
f# Hypertension f#Chapter f#27 f#Drug f#Therapy
for f#Dysrhythmias
f#
Chapter f#28 f#Drug f#Therapy f#for f#Coronary f#Heart
f# Disease f#Chapter f#29 f#Drug f#Therapy f#for f#Shock f#and
Hypotension
f# Chapter
f# 30
f# Drug
f# Therapy
f# for
f#
f# Heart f#Failure
SECTION f#6 f#Drugs f#Affecting f#the f#Respiratory f#System
Chapter f#31 f#Drug f#Therapy f#for f#Nasal f#Congestion f#and f#Cough
, Chapter f#32 f#Drug f#Therapy f#to f#Decrease f#Histamine f#Effects f#and f#Allergic
Response f#Chapter f#33 f#Drug f#Therapy f#for f#Asthma f#and f#Bronchoconstriction
f#
f#Edition f#Geralyn f#Frandsen f#- f#ISBN/ISSN f#9781975136130
Table f#of f#Content
SECTION f#1 f#The f#Conceptual f#Framework f#of f#Pharmacology
f# Chapter f#1 f#The f#Foundation f#of f#Pharmacology: f#Quality f#and
Safety f#Chapter f#2 f#Basic f#Concepts f#and f#Processes
f#
Chapter f#3 f#Medication f#Administration f#and f#the f#Nursing f#Process f#of f#Drug f#Therapy
SECTION f#2 f#Drug f#Therapy f#Throughout f#the f#Lifespan
Chapter f#4 f#Pharmacology f#and f#the f#Care f#of f#Infants f#and f#Pediatric f#Patients f#Medication
Administration f#in f#Pediatrics
f#
Chapter f#5 f#Pharmacology f#and f#the f#Care f#of f#Adults f#and f#Geriatric
f# Patients f#Chapter f#6 f#Pharmacology f#and f#the f#Care f#of f#Pregnant f#or
f# Lactating f#Woman f#Chapter f#7 f#Pharmacology f#and f#Women’s f#Health
Chapter f#8 f#Pharmacology f#and f#Men’s f#Health
SECTION f#3 f#Drugs f#Affecting f#the f#Hematopoietic f#and f#Immune f#Systems
Chapter f#9 f#Drug f#Therapy f#for f#Coagulation f#Disorders
f# Chapter f#10 f#Drug f#Therapy f#for f#Dyslipidemia
Chapter f#11 f#Drug f#Therapy f#for f#Hematopoietic
Disorders f#Chapter f#12 f#Drug f#Therapy:
f#
f# Immunizations
Chapter f#13 f#Drug f#Therapy f#to f#Decrease f#Immunity
f# Chapter f#14 f#Drug f#Therapy f#for f#the f#Treatment f#of
Cancer
f#
,SECTION f#4 f#Drugs f#Affecting f#Inflammation f#and f#Infection
Chapter f#15 f#Inflammation, f#Infection, f#and f#the f#Use f#of f#Antimicrobial
Agents f#Chapter f#16 f#Drug f#Therapy f#to f#Decrease f#Pain, f#Fever, f#and
f#
f# Inflammation f#Chapter f#17 f#Drug f#Therapy f#With f#Corticosteroids
Chapter f#18 f#Drug f#Therapy f#With f#Beta-Lactam f#Antibacterial f#Agents
f# Chapter f#19 f#Drug f#Therapy f#With f#Aminoglycosides f#and
Fluoroquinolones
f#
Chapter f#20 f#Drug f#Therapy f#With f#Tetracyclines, f#Sulfonamides, f#and f#Urinary
f# Antiseptics f#Chapter f#21 f#Drug f#Therapy f#With f#Macrolides f#and f#Miscellaneous f#Anti-
infective f#Agents f#Chapter f#22 f#Drug f#Therapy f#for f#Tuberculosis f#and f#Mycobacterium
avium f#Complex f#Disease f#Chapter f#23 f#Drug f#Therapy f#for f#Viral f#Infections
f#
Chapter f#24 f#Drug f#Therapy f#for f#Fungal f#Infections
f# Chapter f#25 f#Drug f#Therapy f#for f#Parasitic f#Infections
SECTION f#5 f#Drugs f#Affecting f#the f#Cardiovascular f#System
Chapter 26
f# Drug
f# Therapy
f# f# for
f# Hypertension f#Chapter f#27 f#Drug f#Therapy
for f#Dysrhythmias
f#
Chapter f#28 f#Drug f#Therapy f#for f#Coronary f#Heart
f# Disease f#Chapter f#29 f#Drug f#Therapy f#for f#Shock f#and
Hypotension
f# Chapter
f# 30
f# Drug
f# Therapy
f# for
f#
f# Heart f#Failure
SECTION f#6 f#Drugs f#Affecting f#the f#Respiratory f#System
Chapter f#31 f#Drug f#Therapy f#for f#Nasal f#Congestion f#and f#Cough
, Chapter f#32 f#Drug f#Therapy f#to f#Decrease f#Histamine f#Effects f#and f#Allergic
Response f#Chapter f#33 f#Drug f#Therapy f#for f#Asthma f#and f#Bronchoconstriction
f#
